The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
Giuliano
Anna R
AR
Risk Assessment, Detection, and Intervention Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. giuliano@moffitt.usf.edu
Salmon
Daniel
D
D000293:Adolescent; D001005:Anus Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D002648:Child; D005260:Female; D006291:Health Policy; D006801:Humans; D008297:Male; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D012737:Sex Factors; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*
D053918:Papillomavirus Vaccines